A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in Catalent, Inc. stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 343,016 shares of CTLT stock, worth $21.8 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
343,016
Previous 466,751 26.51%
Holding current value
$21.8 Million
Previous $26.2 Million 20.84%
% of portfolio
0.07%
Previous 0.09%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$56.16 - $60.96 $6.95 Million - $7.54 Million
-123,735 Reduced 26.51%
343,016 $20.8 Million
Q2 2024

Aug 13, 2024

BUY
$53.58 - $57.02 $25 Million - $26.6 Million
466,751 New
466,751 $26.2 Million
Q4 2018

Feb 13, 2019

SELL
$29.95 - $46.34 $521,130 - $806,316
-17,400 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$40.12 - $45.55 $172,516 - $195,865
-4,300 Reduced 19.82%
17,400 $793,000
Q2 2018

Aug 14, 2018

SELL
$38.72 - $42.52 $1.59 Million - $1.75 Million
-41,100 Reduced 65.45%
21,700 $909,000
Q1 2018

May 15, 2018

BUY
$39.4 - $47.39 $1.79 Million - $2.15 Million
45,400 Added 260.92%
62,800 $2.58 Million
Q4 2017

Feb 14, 2018

BUY
$37.27 - $43.02 $372,700 - $430,200
10,000 Added 135.14%
17,400 $715,000
Q3 2017

Nov 14, 2017

BUY
$33.75 - $41.67 $249,750 - $308,358
7,400
7,400 $295,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track Jeremy Grantham's Portfolio

Track Jeremy Grantham Portfolio

Follow Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.